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Summary 
T  cells  play an important role in the pathogenesis of diabetes in the nonobese diabetic (NOD) 
mouse.  CD8 cytotoxic T  cell lines and clones were generated from the lymphocytic infiltrate 
in the islets of Langerhans of young (7-wk-old) NOD mice by growing them on (NOD  ￿  B6- 
R.IP-B7-1)F1  islets.  These  cells  proliferate  specifically to  NOD  islets  and  kill  NOD  islets  in 
vitro. The cells  are restricted by H-2K  d, and all bear T  cell antigen receptor encoded by V[36. 
When these CD8 T  cell lines and clones are adoptively transferred to irradiated female NOD, 
young NOD-SCID,  and CB17-SCID nfice, diabetes occurs very rapidly, within 10 d of trans- 
fer and without CD4 T  cells. 
T 
he nonobese diabetic (NOD) 1 mouse develops sponta- 
neous diabetes  and is a good model of human type  1 
or  insulin-dependent  diabetes  mellitus  (IDDM).  Genes 
mapping to the  MHC  play a vital role in susceptibility  to 
IDDM,  and environmental  influences  can also profoundly 
affect the incidence of disease.  IDDM is a T  cell-mediated 
disease  and,  in  its  natural  history,  both  CD4  and  CD8  T 
lymphocytes  are  seen  to  infiltrate  the  pancreatic  islets  of 
Langerhans.  Moreover,  the  ultimate  destruction  of 13 cells, 
on  adoptive  transfer  of IDDM,  requires  both  CD4  and 
CD8 T  cells (1-6). 
The MHC  genes of the NOD  mouse are a major com- 
ponent  of the  genetic  susceptibility  to  diabetes  (7).  The 
MHC  class  II  region  has  been  extensively  studied,  and 
these  mice express  the  unusual  I-Ag  v whose  [3 chain has a 
histidine residue at position 56 and a serine residue at posi- 
tion  57  of the  [3 chain,  whereas  all  other  haplotypes  have 
proline and aspartic acid,  respectively, at these  residues.  In 
addition,  these mice fail  to express  I-E because of a muta- 
tion in the first exon of the E0~ gene (8).  If the NOD  I-A  g7 
is  altered  by substitution  of amino  acid  56  (9)  or by the 
presence of an I-E transgene (9,  10), then diabetes is greatly 
retarded.  The impact of the  MHC  class  I  region has been 
less  studied.  However,  it  is  clear  that  the  relatively  com- 
mon  MHC  class  I  alleles  are  also  important  for develop- 
ment of disease  in NOD  mice.  NOD  mice bred to MHC 
class  I-deficient,  132-microglobulin  gene  knock-out  mice 
tAbbreviations used in this paper: IDDM, insulin-dependent diabetes meUi- 
tus; NOI), nonobese diabetic; NOD-132  mnuu, NOD ￿  MHC class I-defi- 
cient, 132-microglobufin  gene knock-out nfice; lq.T, reverse transcription. 
(NOD-132  m'uu)  develop  neither  insulitis  nor diabetes  (11- 
13).  The particular MHC class I alleles  appear to be impor- 
tant,  as  NOD  mice  congenic for the  MHC  haplotype  of 
CTS mice, which bear NOD  MHC  class II alleles  but dif- 
ferent MHC class I alleles  (unique to CTS), have a reduced 
incidence of diabetes  (14). 
A  number  of studies  have  shown  that  both  CD4  and 
CD8  T  cells  from newly diabetic  donors are  required  for 
adoptive  transfer  of disease  (1-3).  Studies  using cloned T 
cells have also indicated that in adoptive transfer into irradi- 
ated  recipients,  both  CD4  and  CD8  T  cells  are  necessary 
for  optimal  disease  transfer  (4--6).  However,  CD4  T  cell 
clones alone  can cause diabetes  in irradiated  recipients  (5) 
and accelerate diabetes in young NOD  mice that have en- 
dogenous CD8 cells (15). CD4 T  cells  from diabetic NOD 
donors  (16)  have  also been  shown  to  transfer disease  into 
NOD-SCID  mice, which are immunodeficient due to the 
SClD  mutation,  which  prevents  normal  development  of 
functional lymphocytes (17).  It has been suggested on the 
basis of these observations that NOD  APC process soluble 
antigens  from [3  ceils  and  present  these  in  the  context  of 
MHC  class  lI I-A  g7 to CD4 cells,  which can then damage 
islet [3 cells in a delayed-type hypersensitivity response (18). 
Pancreatic  [3 cells,  the target of the autoimmune attack, 
express  MHC  class I but not MHC  class  II molecules  (19, 
20).  CD4  T  cells  must  therefore  recognize  peptides  re- 
leased  from the  [3 cells  and presented on an APC that ex- 
presses  MHC  class II, perhaps resident dendritic  cells.  This 
would  seem  to  require  prior  13  cell  damage,  most  likely 
mediated  by  MHC  class  I-restricted  CD8  T  cells,  since 
there  is  no  insulitis  in  132-microglobulin-deficient  NOD 
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CD8 T  lymphocytes are important in the initiation of dia- 
betes in the NOD  mouse. The absence of insulitis or dia- 
betes in these NOD-[32m  ~'n mice has been attributed to the 
fact  that  CD8  T  cells  require  MHC  class  I  for  develop- 
ment.  In  addition,  diabetic  spleen  cells  can  adoptively 
transfer disease into the NOD-132m  m':~ mice, but since dis- 
ease  onset is  delayed compared  with  normal NOD  nfice 
(12), this suggests that CD8 T  cells also play a direct effec- 
tot role in causing diabetes. 
There are  few reports of CD8 T  cell clones reactive to 
islets  in  the  literature.  Nagata  et  al.  (6)  have  described 
NOD-derived CD8  T  cell  clones  that  will  only transfer 
disease in the presence of CD4 T  cells, and Shimizu et al. 
(5) showed that their CD8 T  cell clones would not transfer 
disease,  even in the  presence of CD4 T  cells.  There have 
been no previous reports of CD8  T  cells transferring dis- 
ease in the absence of CD4 T  cells. 
T  cells recognize antigen as pep{ides that are complexed 
with  MHC  molecules.  However,  recognition of antigen 
alone is not sufficient to activate the cell and, instead, may 
induce anerg3." (21, 22). A second signal is required, and this 
may  be  delivered  by  interaction of the  molecule  CD28 
with molecules of the B7 fanaily ofcostimulato  W molecules 
on APC  (23,  24).  Much evidence suggests that B7-CD28 
interaction activates  CD4  T  cells  and  is  required for  the 
production of the  cytokines IL-2 and IFN-y (23,  25-28). 
Naive CD4 T  cells require both ligand and costimulator to 
be present at the same APC  fbr optimal T  cell activation 
(29).  The  role  of this  costimttlato  W  pathway  for  CD8  T 
cells has been more controversial, although, as with CD4 T 
cells,  it has been shown that CD8 T  cells can be activated 
in the presence of B7  (30).  Tumors that express B7-1  can 
become  immunogenic and  activate  CTL,  bypassing  the 
need for exogenous help from CD4 T  cells (31-33). It ap- 
pears that the costimulatory  interaction is necessary for acti- 
vation of the cells but not for effector function (34). 
Here we report that when islet-specific CD8 T  cell clones 
derived from islet-infiltrating  cells of young NOD mice are 
activated  in  the  presence  of the  costimulator  B7-1,  ex- 
pressed on NOD 13 cells by means of the rat insulin promo- 
tor,  they can very rapidly and efficiently cause diabetes in 
irradiated NOD,  NOD-SCID,  and CB17-SCID mice in 
the absence of CD4 T  cells. 
Materials  and Methods 
Mice.  Female 7-wk-old NOD/Caj mice were used to gener- 
ate  T  cell  clones  and as  recipients  in adoptive transfer  experi- 
ments.  Mice were housed in specific pathogen-free conditions. 
In this colony, female mice develop  diabetes from 12 wk of age, 
reaching an incidence of 90% by 24 wk. BALB/c and C57BL/6 
mice (The Jackson  Laboratory, Bar Harbor, ME) were used for in 
vitro eytotoxicity assays. In addition, NOD-SCID (The Jackson 
Laboratory), CB17-SCID (H-2a), and B6-SCID (H-2  b) mice were 
used as recipients for adoptive transfer. 
Generatiotl and Propagation of T Cell Clones.  T  cell clones  were 
generated from the islet infiltrate of 7-wk-old female NOD nfice. 
The infiltrating  lymphocytes were grown in culture in Clicks me- 
dium supplemented with 5% fetal bovine serutn  and 5  U  IL-2 
(EL-4 supernatant)  at 37~  and 5% CO> After 7 d, the cultures 
were stimulated  with irradiated  islets from  (NOD ￿  C57BL/6J- 
RIP B7-1)FI  hybrid mice, which express the costinmlator B7-1 
on the islets of Langerhans  (35) as a source of antigen. The islets 
were isolated by collagenase digestion as described previously  (4). 
After further restinmlation with two cycles of antigen at 2-wk in- 
tervals, the cells were then cloned by linliting  dilution. These cul- 
mres were maintained on Clicks medium supplemented with 5% 
fetal bovine sernm and 5 U IL-2.  Islet antigen, in the form of ir- 
radiated  islets fi'om  (NOD  ￿  C57BL/6J-RIP  B7-1)F  1 hybrid 
mice, was added eve W 2 wk. 
Flott., Cytometr}'.  Cells were stained with the following mAbs: 
FITC-conjugated anti-CD4 and anti-CD8 (GIBCO Blq,  L. Gaith- 
ersburg, MD), PE-conjugated anti-c~/13-TCR:  FITC-conjugated 
anti-V[3 2, 3, 5, 6, 7, 8, 9.  10,  11,  12.  14,  17; FITC-conjugated 
anti-CD44; FITC-conougated  anti-CD69: FITC-conjugated anti- 
heat  stable antigen; anti-CD28 (PharMingen, San  Diego,  CA); 
anti-c~4 integrin or CD49d (R.l-2), and anti-intercellular adhe- 
sion molecule  1 (YN/1).  FITC-conjugated anti-hamster antibody 
(CALTAG Laboratories, South San Francisco, CA) was used with 
anti-CD28, and FITC-conjugated anti-rat lgG antibody (Hyclone 
Laboratories,  Inc.,  Logan,  UT)  was  used  with anti-c~4 integrin 
and anti-lCAM-1. The  cells were  incnbated with  the  directly 
conjugated antibodies for 3{) nfin at 4~  in PBS containing 1% FCS 
and 0.1% sodimn azide and then washed and analyzed on FACS '~ 
IV (Becton Dic~nson hmnunocytometry  Systems, Mountain View, 
CA). When nnconjugated antibodies were used, there was a fur- 
ther incubation with the secondary antibody using the same con- 
ditions before analysis. 
Cytoki,e P~z!l~le.  Total cellular 1LNA was prepared  from 5 ￿ 
10" T cells using RNAzol t3 (Biotecx Laboratories Inc.,  Houston, 
TX) according to the manufacturer's instructions. 1LNA was then 
primed at  55~  using oligo  dT(12-18)  (GIBCO BRL)  and re- 
verse transcribed  at 37~  with 300 U of Maloney murine leuke- 
mia virus reverse transcriptase (GIBCO BRL)  in a final volume of 
40  I~1  containing 0.55  l-tl RNAsin (Promega  Corp.,  Madison, 
WI), 4 I.d dithiothreitol, 8 I-tl  5￿  buffer (Tris-HCl, KCI, MgCI2), 
and 25  ~mol dNTP  (Pharmacia  Biotech Inc., Piscataway.  NJ). 
The reaction was tenninated by heating to 70~  for  10 rain, and 
the  final volume was made  to  100 I*1. 2  gl of cDNA was then 
used for subsequent PCRs. 
PCIL  reactions  were  carried  out  using 1 U  Taq polymerase 
(Promega Corp.)  in a reaction containing  2.5 ~1 10 ￿  PCR buffer 
(500 mM KC1, 100 mM Tris-HCl, pH 9.0, at 25~  1% Triton 
X-100),  1.5 mM MgC12, {).25 t*1 dNTP mix (25 nflVl), 10{11 ng 
each primer, and 2 btl cDNA in a final volume of 25 I~1. PeR. 
primers  for actin,  IL-2,  IFN-y, IL-4,  TNF-c~, and TNF-]3 were 
originally purchased  from CLONTECH (Palo Alto,  CA).  Prim- 
ers for IL-5,  IL-12,  TGF-IB (36), and perforin (37) were synthe- 
sized in the Keck Facility."  of Yale University. 
PC1L primer sequences were as follows. Actin 5' primer: GTG 
GGC CGC TCT AGG CAC CAA, 3' primer: CTC TTT GAT 
GTC ACG CAC GAT TTC; IL-2 5' primer: ATG TAC AGC 
ATG CAG CTC GCA TC, 3' primer: GGC TTG TTG AGA 
TGA TGC TTT GAC A;  IFN-y 5'  primer: TGA ACG CTA 
CAC ACT GCA TCT TGG, 3' primer: CGA CTC CTT TTC 
CGC TTC CTG AG; TNF-c~ 5' primer: ATG AGC ACA GAA 
AGC ATG ATC CGC, 3' primer: CC AAA GTA GAC CTG 
CCC  GGA CTC;  TNF-]3 5'  primer: TGA CAC  TGC  TCG 
GCC  GTC TCC  A,  3'  primer: GTT GCT CAA AGA GAA 
GCC ATG TCG; IL-4 5' primer: ATG GGT CTC AAC CCC 
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GAA GTC; IL-5 5' primer: GAA AGA GAC CTT GAC ACA 
GCT G, 3' primer: GAA CTC TTG CAG GTA ATC CAG G; 
IL-12 5'  primer: ATG GCC ATG TGG GAG CTG GAG, 3' 
primer:  TTT  GGT  GCT  TCA  CAC  TTC  AGG;  TGF-[3  5' 
primer:  ACA  GGG  CTT  TCG  ATT  CAG  CGC,  3'  primer: 
CCC  TTG GGC TCG TGG ATC  CAC;  perforin 5'  primer: 
GCC ACG ACC TGT CCC TGC, 3' primer: TTG GTT CCC 
GAA GAG C.  The PCR reaction profile used for all the cyto- 
kines except pefforin was denaturation at 94~  for l  min, anneal- 
ing at 55~  for 1 rain, and extension at 72~  for 2 min for 30 cy- 
cles followed by an extension at 72~  for 7 rain. For the perforin 
reaction, the extension temperature used was 65~ 
TCR Characterization.  cDNA, synthesized as above, was am- 
plified using primers for C]3 (CTG CTC GGC CCC AGG CCT 
CT) and V[36 (GGC (;AT CTA TCT GAA GGC TA). A single 
band was visualized after electrophoresis on 1% agarose gel (GIBCO 
BILL). The sample was purified using a DNA purification column 
(Wizard; Promega Corp.) and sequenced on both strands using an 
automatic sequencer (model 737; Applied Biosystems, Inc., Fos- 
ter City, CA). The cl chain was cloned similarly, using a degener- 
ate  primer  for  Vex  purchased  from  Operon  Technologies  Inc. 
(Mameda, CA) and a Ce~ primer (ATA TCT TGG CAG GTG 
AAG CTT GT) using conditions described (38). 
Thymidine Incorporation Proliferation Assays.  104 T  cells were in- 
cubated with 10-20 purified irradiated islets from 6-wk-old NOD 
or (NOD  X C57BL/6J-ILIP B7-1)F  1 hybrid mice in a V-bottom 
plate for 72 h. The cultures were pulsed with 1 txCi [3H]th~anidine 
(New England Nuclear, Boston, MA) and harvested 16 h later. 
Chromium Release Assay.  Islets  were  isolated  as  above  from 
6-wk-old NOD  mice and dispersed into single cells by washing 
once in Ca  2+- and Mge+-free HBSS (GIBCO BILL) and then in- 
cubation with 1 X Trypsin-EDTA (GIBCO BILL) at 37~  for 10 
nfin. The  islets  were  cultured overnight in Clicks medium and 
5% FCS. The islet cells were labeled with 100 ~Ci of Na2SlCrO4 
(Aniersham Corp.,  Arlington Heights,  IL) in 0.2 nil Clicks me- 
dium with 5% FCS at 37~  for 2 h, washed three times, and re- 
suspended in Clicks medium with 5% FCS at  10  s cells/ml. The 
cells  were  seeded  in a  round-bottom 96-well plate at  10  4 cells/ 
well. Effector cells  were added in E/T ratios of 50 : 1, 25 : 1, and 
10 : 1 to each well in duplicate. Culture medium was added to a 
set of target cells for estimation of spontaneous cell lysis. Total cell 
lysis was  detemfined by lysing the  cells  with hydrochloric acid. 
The plates were centrifuged at  100 g for 2 min and incubated at 
37~  for 6,  12,  and 22  h.  120  ILl of supernatant was  harvested 
from  each  well,  and  the  radioactivity  measured  in  a  gamnla 
counter (LKB, Wallac, Gaithersburg, MD). Specific lysis was cal- 
culated as percent lysis =  100  3<  (test cpm -  spontaneous cpm)/ 
(total cpm  -  spontaneous cpm).  As control target cells,  Con A 
blasts were generated by incubating spleen cells for 48 h with 2.5 
p.g/ml  Con A,  and then  the  cells  were  labeled with  100  p,  Ci 
Na2SlCrO4 for 1 h and used in the cytotoxicit  3' assays as above. 
Adoptive Transfer.  Female NOD  mice  (7  wk  old)  irradiated 
with 725 rad from a caesium source, 2-3-wk-old female NOD- 
SCID mice, 2-3-wk-old CB17-SCID (H-2  a) mice, or 3-wk-old 
B6-SCID (H-2  b) mice were used in the adoptive transfer experi- 
ments.  In  the  initial experiments  using transfer  into  irradiated 
NOD  mice,  the  CD8-cloned T  cells  (5  ￿  106) were  injected 
alone or admixed with CD4 T cells (5 ￿  106), purified by CD4 T 
cell isolation columns (Pierce Cheinical Co., R`ockford, IL) from 
the spleen cells of recently diabetic NOD mice (95% purity). As a 
positive control, animals were injected with 5  ￿  106 purified CD4 
cells mixed with 5  ￿  106 purified CD8 T  cells or with whole di- 
abetic spleen cells.  As a  negative control, animals were  injected 
with 5 X  106 purified CD4 T cells alone or with PBS. The irradi- 
ated mice were injected intravenously 24 h  after irradiation and 
monitored for glycosuria using Diastix (Ames, Elkhart,  IN), and 
diabetes was confimled by a blood glucose measurement of > 13.9 
mmol (250 mg/dl). The pancreas was examined by immunohis- 
tology.  In later experiments involving the  various animals with 
the SCID mutation, only the cloned CD8 T  cells were used. 
lmmunohistopathological Analysis.  Pancreata from diabetic nfice 
and control animals which had been irradiated and injected with 
saline were either fixed in 10% buffered fomlalin or processed for 
immunohistochemistry by fixation in paraformaldehye lysine pe- 
riodate.  After 24 h,  the pancreata were sucrose infused, embed- 
ded in Tissue Tek OCT (Miles Inc., Elkhart,  IL),  and frozen in 
isopentane. The portion of the pancreas that was fixed in fommlin 
was  paraffin embedded and stained with hematoxylin and eosin. 
The sections were  microscopically examined for the presence of 
insulitis--the presence of mononuclear cell infiltration in the islets 
of Langerhans.  For  inmmnohistochemistry, 7-I.tm-thick  frozen 
sections were stained with biotinylated YT4.3 antibody recogniz- 
ing CD4,  TIB  105  antibody recognizing CD8,  B220  antibody, 
which stains B  cells, and anti-TCR` V]36 antibody (PharMingen). 
The color was developed using dianfinobenzidine tetrahydrochlo- 
ride and nickel ammonium sulphate. Sections were counterstained 
with hematox3,1in. 
Cell Tracing.  The cloned T  cells  were labeled with the fluo- 
rescent dye Dil (Molecular Probes, Inc., Eugene, OR.) at 37~  for 
30 min and washed three times in PBS, and 5  X  1(16 cells  were 
transferred as above. This dye is extremely useful because sections 
containing cells stained with the dye can also be stained by con- 
ventional immunohistochemistry. Mice were killed at 24 h and at 
5 d after becoming diabetic, and the tissue was prepared for fro- 
zen section as above. Sections were first viewed under fluorescent 
microscopy, photographed, and then stained with the appropriate 
mAbs for immunohistochemistry. 
Results 
NOD CD8 T  Cell Lines Are Generated by Growing Cells  fiom 
the Islets of Prediabetic NOD Mice on Islets  fiom  B7-1-expressing 
(NOD  X  B6)F  I Hybrid Mice.  The T  cell lines isolated from 
pancreatic islets and stimulated repeatedly  with  islets from 
(NOD  X  C57BL/6J-tLIP B7-1)FI hybrid mice were cloned 
by limiting dilution and were  assessed  for  their  ability to 
proliferate  in  response  to  islets  from  NOD  mice  and  for 
their surface  phenotype.  Oligoclonal T  cell lines D2,  C7, 
B11, and F8 stained predominantly or exclusively for CD8. 
The T  cell clones G9 and Bll-5.2,  derived by further lim- 
iting dilution, expressed CD8 as shown in Fig.  1. 
The  T  cell  clones  G9  and  Bll-5.2  expressed  identical 
surface markers by flow cytometry after staining with nLAbs 
as illustrated for clone G9 in Fig.  1. The cells bear the acti- 
vation markers  CD28  and CD44  but not HSA or  CD69. 
In addition,  they express  the  adhesion molecules oe4-inte- 
grin and ICAM-1. 
The  CD8  T  cell  clones  G9  and  Bll-5.2  both  express 
V[36. This is shown by staining with anti-V]3 mAb (Fig.  1). 
The expressed TCtL of G9 was further characterized by se- 
quencing after amplification by reverse  transcription (RT) 
PCR.  This  revealed  that  the  G9  TCIL  consists  of V]36, 
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The T cell clone G9 has been stained with mAbs as described in the text and analyzed by flow cytometry. 
DI31.1, J 132.3 and Vot 15, and Jcl8 (nomenclature as reported 
in references 39, 40), and the translated amino acid sequences 
are shown in Fig. 2. 
CD8 T  Cell  Oligoclonal Lines and  Clones Proliferate to NOD 
Islets.  When tested for proliferative responses to NOD  is- 
lets by thymidine incorporation, the cells respond by pro- 
liferating, with stimulation indices >  10 and some consider- 
ably more, as shown in Table 1. The response of the cloned T 
cells to NOD  islets was similar to that of the cloned T  cells 
to the islets of(NOD  ￿  C57BL/6J-R.IP B7-1)F  1 hybrid mice 
(data not shown). 
CD8 T  Cell Clones Express the Cytokines IFN-%  TNF-a, 
TNF-~8,  and the Effector Molecule Petforin.  The cytokine pro- 
file of the T  cell clones was tested by I<T-PCR., and the cells 
express typical cytokines of CD8-cytotoxic T  cells: IFN-y, 
TNF-(x, TNF-[~, and the effector molecule perforin, as shown 
in Fig. 3.  In addition, the cells were tested for, but do not 
express, IL-2, IL-4, IL-5, IL-12, and TGF-[3. 
CD8  T  Cell Clones  Are Cytotoxic to NOD  Islets In  Vitro. 
The T  cell clone designated G9 showed cytotoxicity toward 
islet cells from NOD  mice when tested in a SlCr release as- 
say after 6,  12, and 22 h. Specific lysis was demonstrated by 
this in vitro test as shown in Fig. 4 A  and occurs at all time 
Vot 15 
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Figure  2.  Sequence  of clone G9 TCR cDNA translated into protein 
and showing the junctional regions of the oL and [3 chains. 
points,  although  the  optimal time was  shown  to be  12  h. 
Spontaneous  lysis was  20-30%  at  the  earlier time  points, 
rising to 40-50% at 22 h. Thus, subsequent 51Cr release as- 
says were performed using the optimal 12-h time point for 
assessment. In addition, a SlCr release assay was performed us- 
ing islet cells from the NOD  mouse (H-2 KaD  b) and com- 
pared with  islet cells from  BALB/c  (H-2  a)  and  C57BL/6 
(H-2  b) mice. The cloned T  cells showed cytotoxicity toward 
islet cells from NOD  and BALB/c mice but not C57BL/6 
mice at 12 h, indicating MHC  restriction by K a (Fig. 4  B). 
In addition, this effect was islet specific, as shown by lack of 
cytotoxicity towards  Con  A  blasts  used  as  control  target 
cells (data not shown). 
CD8  T  Cell  Lines  Stimulated  in  the Presence of B7-1  Do 
Not Require CD4 T  Cells to Cause Diabetes.  To determine if 
the CD8  T  cell lines generated by this method can transfer 
disease in vivo, the cloned T  cell lines were  injected into 
irradiated NOD  mice  either alone or mixed with CD4  T 
Table  1.  CD8 T Cell Lines Proliferate to NOD Islets 
CD8 T cell  Proliferation  Proliferation 
line/clone  without antigen  with antigen 
cpm 
Bll  102  10,015 
C7  241  2,703 
D2  184  14,418 
F8  130  44,142 
G9  154  14,270 
Thymidine incorporation  proliferation assay demonstrating  prolifera- 
tion of the oligoclonal CD8 cell lines C7, D2, F8, Bll, and the clone 
G9 to NOD islets. This is shown as the mean of the proliferation in du- 
plicate of the cells with no antigen or in the presence of antigen (10 
NOD islets). 
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NOD Mice 
Days after adoptive transfer 
T cell line/clone  4  5  6  7  8  9  15 
Figure 3.  Agarose gel showing 
PCtk products derived from clone 
G9  using primers for  actin as  a 
control,  the  cytokines IFN-',/, 
TNF-(x and -[3, and the  effector 
molecule pefforin. 
cells, as it had been shown previously by other investigators 
(4, 6)  that CD4 T  cells were required to cause disease. All 
the T  cell lines tested caused disease within 9 d of injection, 
and the addition of CD4 T  cells did not significantly alter 
the time course of disease, as shown in Table 2. In the sub- 
sequent experiments, only the CD8 T  cell clones were used. 
These results have been reproduced on at least four occa- 
sions with the clone G9. 
To examine further the ability ofCD8 T  cells to initiate 
and cause diabetes, their ability to  adoptively transfer dis- 
ease was tested in NOD-SCID animals. We observed that 
the G9 clone and subclones of G9 and subclones of the D2 
line caused diabetes in young NOD-SClD  mice in the ab- 
sence ofcoinjected CD4 T  cells up to 14 d after transfer. 
To confirm the MHC restriction of the CD8 T  cell clones, 
the cells were transferred into CB17-SCID (H-2  d) and B6- 
SCID (H-2  b) mice. G9 can transfer diabetes to CB17-SCID 
mice but not to B6-SCID mice, which is further evidence 
of restriction to K d. These results are shown in Table 3. 
Immunohistology of the islets taken from mice that de- 
veloped diabetes at 5 d after injection of CD8 T  cell-cloned 
lines, either alone or with CD4 T  cells, in irradiated NOD 
A 
6O 
50 
"~  40 
o  ~ ~o 
N  20 
10 
I"1  6 hours  B 0 . 
￿9  12 hour~ 
A  ~  ~o 30-  .y   2o. 
10- 
i 
10:1  30:1  50:1 
Eft 
rsfllo 
oeNOD  BALB/c 
u  ~ 
10:1  25:1  50:1 
E/T 
ratio 
Figure  4.  SlCr  release  cytotoxicity  assay showing the  cytotoxicity  of 
clone G9 for NOD islets at three different times of incubation (/t). MHC 
restriction  for K  d is shown by the assay in (B), in which clone G9 demon- 
strates cytotoxicity  for islets from NOD mice (KdD  b) and BALB/c (KdD  d) 
mice but not C57BL6 mice (KbDb). This assay was analyzed  after 12 h. 
No specific lysis was demonstrated when control targets (Con A blasts) 
were used from each of these types of mice (data not shown). 
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G9  3/6  6/6 
Bll  0/2  1/2  2/2 
C7  0/2  2/2 
C7 +  CD4  0/2  2/2 
D2  0/3  0/3  0/3  0/3  3/3 
D2 +  CD4  0/3  3/3 
F8  0/2  1/2  1/2  1/2  1/2  2/2 
F8 +  CD4  0/l  0/1  0/1  0/1  1/1 
CD4 alone  0/3  0/3  0/3  0/3  0/3  0/3 
CD4 +  CD8  0/2  0/2  0/2  0/2  0/2  0/2 
Diabetic spleen  0/2  0/2  0/2  0/2  0/2  0/2 
PBS  0/3  0/3  0/3  0/3  0/3  0/3 
0/3 
2/2 
2/2 
0/3 
The numbers of mice developing diabetes are shown at various times 
after adoptive transfer to irradiated NOD mice. In addition, positive 
control mice were observed that had been transferred with 107 NOD 
diabetic spleen cells or 5 ￿  106 CD4 T cells + 5 ￿  106 CD8 T cells de- 
rived from diabetic splenocytes  alone. Negative controls were mice that 
were injected with 5 X 10  6 purified CD4 T cells or mice that were ir- 
radiated but not transferred. Negative control mice did not develop di- 
abetes until >40 d after transfer. 
mice showed extensive destruction of the islets. Irradiated 
control mice did not develop either insulitis or diabetes at 
this time. On staining with anti-CD4 and anti-CD8 anti- 
bodies, mice that received CD8 T  cells had only CD8 T  cells 
in appreciable numbers, whereas the mice that received CD8 
T  ceils coinjected with CD4 cells had both types of cells,  as 
might be expected. A similar picture is seen in the diabetic 
NOD-SCID or CB17-SCID mice transferred with CD8 T 
cell clones. The cells infiltrating the islets in SCID mice all 
bear VI36. 
hnmunohistochemistry  of irradiated NOD, NOD-SCID, 
and CB17-SCID mice that had become diabetic is shown 
in Fig. 5. 
When cells were labeled with the fluorescent dye DiI, it 
can be seen that large numbers of CD8-cloned T  cells had 
reached and invaded the islet by 24 h, and these were still 
present at the time diabetes occurred 4 d later (Fig. 6). We 
have shown that it is possible to  successfully fluorescently 
label cells that can also be visualized and stained with con- 
ventional immunohistochemistry. When these sections were 
stained using anti-CD8 and anti-V[36, we saw that the cells 
that were present in the diabetic animals were  CD8 +  and 
V136  +,  as expected.  No  infiltration was seen in the irradi- 
ated control animals (not shown). 
Thus, it has been shown that CD8-cloned T  cells, when 
optimally activated, can home to the islet and rapidly adop- 
tively transfer diabetes in the absence of CD4 T  cells. Table 3.  Adoptive Transfer of CD8 T  Cell Clone G9 and Subclone G9C8 to SCID Mice 
Days after adoptive transfer 
Strain  MHC  5  6  7  8  9  10  11  12  13  14  35 
NOD-SCID  KdD  b  2/10  5/10  6/10  6/10  6/10  7/10  7/10  7/10  7/10  8/10  8/10 
AgTEo 
CB17-SCID  KdD  a  0/7  0/7  2/7  4/7  4/7  4/7  4/7  4/7  4/7  4/7  4/7 
AdE  d 
C57BL/6-SC1D  KbD  b  0/2  0/2  0/2  0/2  0/2  (1/2  0/2  0/2  0/2  0/2  0/2 
AbE  o 
The numbers of mice developing diabetes are shown at various times after adoptive transfer to NOD-SCID, CB17-SCID,  and C57BL/6-SCID 
mice. The numbers for transfers into NOD-SCID and CBI7-SCID mice are the totals over at least three experiments. The mice that did not de- 
velop diabetes were observed for at least 35 d after transfer. 
Discussion 
Many lines of evidence suggest that CD8 T  cells are im- 
portant  in  the  pathogenesis  of IDDM.  In human  IDDM, 
CD4 and CD8 cells are found in the postmortem pancreatic 
sections of patients  who have  died  at  the  onset of disease 
(41, 42) and in pancreatic biopsy specimens from newly di- 
agnosed  patients  (43).  Identical  twins  who  are  discordant 
for  IDDM  and  who  have  received  pancreatic  transplants 
from the nondiabetic  twin rapidly developed a recurrence 
of disease.  Histology of the  pancreatic  grafts  showed  that 
the infiltrating cells were predominantly CD8 T  cells  (44). 
There is also evidence that CD8 T  cells play a key role in the 
NOD  animal  model  of diabetes.  However,  CD8  T  cell 
clones are difficult to isolate, and, consequently, there have 
been few studies to date reporting these cells  (5,  6, 45). 
This study has shown that it is possible to isolate islet-reac- 
tive  CD8  cytotoxic  T  lymphocytes from 7-wk-old  NOD 
mice,  a  time point at which  the animals  have insulitis  but 
would not become diabetic  for several  weeks.  These  cells 
are capable of destroying pancreatic [3 cells and causing dia- 
betes  in the irradiated  NOD  mouse without cotransferred 
CD4 T  cells,  and diabetes appears much more rapidly (5 d 
after transfer)  than  has been demonstrated  in any previous 
study, 21 d being the earliest time reported by Nagata et al. 
(6).  In addition, the CD8-cloned T  cells  could transfer dis- 
ease in NOD-SCID/Lt  mice as well as CB17-SCID mice 
(matched  for the  MHC  class  I  molecule  Ka),  which  lack 
functional endogenous lymphocytes. These CDS-cloned T 
cells  differ  from previously  isolated  diabetogenic  CD8  T 
cell  clones  (4-6)  in  that  they have  been stimulated  by an 
antigenic  target  that  bears  the  costimulatory  B7-1  mole- 
cule.  Pancreatic  13 cells in the NOD  mouse express MHC 
class I molecules (19, 20), and there is no evidence that they 
express  the  B7-1  or B7-2  costimulatory  molecules  under 
normal  circumstances  in  vivo.  One of the  mechanisms  of 
peripheral  tolerance is thought to involve the induction of 
anergy by tissue  cells,  which do not express  costimulatory 
molecules,  protecting  them from attack  by T  cells  recog- 
nizing self-molecules. One of the problems that may be en- 
countered in the isolation of CD8 cytotoxic T  lyrnphocytes 
is that islet antigens presented by pancreatic islet 13 cells, which 
do not have costimulatory molecules present,  cannot opti- 
mally activate the cells. Therefore, cells that are stimulated in 
vitro by targets that lack a costimulatory second signal may 
be rendered anergic and be difficult to maintain. 
The CD8 T  cells,  can, once activated,  proliferate in the 
absence of the costimulatory signal,  as shown by the in vitro 
proliferation  to NOD  islets  that do not bear B7.  It is not 
known whether  these  cells  would become anergic  if cul- 
tured  with  NOD  islets  lacking  the  costimulatory  signal. 
The cells  demonstrate  in vitro cytotoxicity as measured in 
5lCr release assays toward NOD  islets,  and these cells  have 
a very marked abili W to destroy the pancreatic islets in vivo. 
Histologic studies have shown that at the time that the ani- 
mals develop diabetes,  most of the 13 cells in islets  are com- 
pletely destroyed, and the architecture is very distorted. It is 
possible  that the relatively low in vitro cytotoxici  W is due 
to  the  fact  that  pancreatic  islets  are  poor  targets  for these 
cytotoxic assays and,  in previous studies,  high specific lysis 
was only found for CD8 T  cell lines and not for clones (6) 
or at high E/T ratios of 50:1  (5).  The fact that the CD8 T 
cell lines and clones can cause rapid disease in NOD  mice, 
which do not have BT-1  expression on the pancreas,  indi- 
cates that B7-1  is not required  either  for specific recogni- 
tion or fbr effector function. 
It is interesting that these cells have been generated from 
7-wk-old mice that are likely to have some insulitis but are 
a number of weeks away from the development of diabetes. 
It is possible that a naive subset oflymphocytes has been stim- 
ulated and induced to react by activation that includes costim- 
ulatot3., signals.  Alternatively, it suggests that cells are already 
present at this time that may be able to mediate significant 
damaging effects on the pancreatic islets,  given appropriate 
stimulation,  and that these may well be cells  that play a role 
in the initiation of the disease process. The presence of cells 
72  CD8 T Cell Clones Rapidly Transfer Diabetes in Nonobese Diabetic Mice Figure 5.  Immunohistochemistry  showing staining with anti-CD8 and anti-V~6 of  pancreatic sections of  mice transferred with clone G9 and taken at 
the time diabetes occurred. An irradiated NOD mouse is shown in A, a NOD-SCID mouse in B, and CB17-SCID mouse in C. 
in the islets  of  young NOD  mice that are capable of inflict- 
ing damage has already been suggested by studies in which 
islet-infiltrating T  cells from prediabetic animals can transfer 
diabetes to NOD-SCID animals as rapidly as the islet-infiltrat- 
ing cells from diabetic mice (46). 
The importance  of T  cells  expressing TC1K encoded by 
V~36 has previously been suggested by Edouard et al.  (47), 
who showed that ifa population ofT cells were depleted of 
TC1K-V~6-bearing cells,  these  cells  could no longer adop- 
tively transfer diabetes.  The present study highlights the im- 
portance ofV~36  +  CD8 T  cells.  Of a number of the initial 
oligoclonal CD8 T  cell lines generated,  only those that ex- 
pressed predominantly V~6 were able to adoptively transfer 
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diabetes in vivo, and subsequently, all the T  cell clones gen- 
erated that were capable of causing disease expressed TC1K 
encoded by V~6. The TCIK encoded by V0d5 (nomencla- 
ture according to reference 39) has previously only been re- 
ported by Pircher et al. (48). The TCR does not resemble the 
o~ or ~  chain sequences described elsewhere (6, 45), suggest- 
ing that a different islet autoantigen is recognized by the CD8 
T  cell clones reported here, which appear to be involved in 
disease initiation rather than effector function. 
The strongest evidence that CD8 T  cells may be impor- 
tant in the initiation of type 1 diabetes in the NOD  mouse 
comes from studies in which NOD mice lacking ~2-micro- 
globulin (and hence MHC class I and most CD8 T  cells) de- Figure 6.  Pancreatic  sections taken at (A) 1 and (B) 5 d after transfer of clone G9 labeled with DiI showing labelling of the cells within the islets  with 
the lipophilic dye. 
velop neither insulitis nor diabetes (11-13).  Our study has 
indicated that CD8  T  cells that have the potential to cause 
disease are present in the early stages of insulitis, and, given 
optimal activation conditions in vitro, are capable of caus- 
ing diabetes, not only in the irradiated adoptive transfer model 
but also in young NOD-SCID  or CB17-SCID  mice that 
express the appropriate restriction element for TCR  recog- 
nition of antigen.  CD8  T  cells, therefore,  have  the ability 
both to initiate damage in young animals as well as to per- 
form the final effector function. 
A  number of models exist for the pathogenesis of type 1 
diabetes that do not suggest that CD8 T  cells play any role 
in initiation of the  disease process. In light of the fact that 
activated CD8 T  cells can cause diabetes in young SCID an- 
imals, we suggest a model for the pathogenesis of diabetes, 
whereby activated CD8  T  cells, which may originate out- 
side the  pancreas  (for instance,  in  the  peripancreatic lymph 
nodes), may play an initiating role in the damage to pancre- 
atic islets. This is possible because they have the effector mol- 
ecules capable of causing damage to the [3 ceils. This could 
lead to  a  release of soluble islet antigens, which  may then 
be taken up by professional APC within the islet and pre- 
sented  to  CD4 +  T  cells, which  have  different  regulatory 
and effector functions. Amplification and diversification of 
the antigenic response, perhaps by activation orB cells, can 
then  lead  to  the  growth  and  activation  of effector  CD4 
cells, which predominate over any regulatory elements that 
may be present.  Cytokines such as IL-2 produced by these 
cells  could  then  play a  role  in  recruiting  further  CD8  T 
cells and activating them.  CD4  T  cells can also recruit and 
activate macrophages to produce other effector molecules, 
such as nitric oxide, all of which could act together to dam- 
age sufficient numbers of islet [3 cells to cause diabetes. 
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